LZD administration significantly decreased the expressions of TLR-2, MyD88, and TNF-α and markedly promoted the generation of duodenal mucosal PGE2, compared to the ulcer control group, thus alleviating duodenal ulcer formation and decreasing the size of ulcers. Here, TNF is linked to ulcer disease.